These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 12900850)

  • 1. Isolated adrenocorticotropic hormone deficiency presenting with hypercalcemia in a patient on long-term hemodialysis.
    Kato A; Shinozaki S; Goga T; Hishida A
    Am J Kidney Dis; 2003 Aug; 42(2):E32-6. PubMed ID: 12900850
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical manifestation of hypercalcemia caused by adrenal insufficiency in hemodialysis patients: a case-series study.
    Sakao Y; Sugiura T; Tsuji T; Ohashi N; Yasuda H; Fujigaki Y; Kato A
    Intern Med; 2014; 53(14):1485-90. PubMed ID: 25030558
    [TBL] [Abstract][Full Text] [Related]  

  • 3. 1alpha(OH)D3 One-alpha-hydroxy-cholecalciferol--an active vitamin D analog. Clinical studies on prophylaxis and treatment of secondary hyperparathyroidism in uremic patients on chronic dialysis.
    Brandi L
    Dan Med Bull; 2008 Nov; 55(4):186-210. PubMed ID: 19232159
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Adrenal crisis presented as acute onset of hypercalcemia and hyponatremia triggered by acute pyelonephritis in a patient with partial hypopituitarism and pre-dialysis chronic kidney disease.
    Yamada S; Arase H; Morishita T; Tsuchimoto A; Torisu K; Torisu T; Tsuruya K; Nakano T; Kitazono T
    CEN Case Rep; 2019 May; 8(2):83-88. PubMed ID: 30456557
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Acute effect of pamidronate on PTH secretion in postmenopausal hemodialysis patients with secondary hyperparathyroidism.
    Lu KC; Yeung LK; Lin SH; Lin YF; Chu P
    Am J Kidney Dis; 2003 Dec; 42(6):1221-7. PubMed ID: 14655194
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hypercalcemia in an euthyroid patient with secondary hypoadrenalism and diabetes insipidus due to hypothalamic tumor.
    Hotta M; Sato K; Shibasaki T; Demura H
    Endocr J; 1998 Dec; 45(6):773-8. PubMed ID: 10395233
    [TBL] [Abstract][Full Text] [Related]  

  • 7. May primary empty sella turcica be a cause of isolated ACTH deficiency? A case report and the review of related literature.
    Gulcan E; Gulcan A; Taser F; Korkmaz U; Erbilen E
    Neuro Endocrinol Lett; 2007 Dec; 28(6):745-8. PubMed ID: 18063931
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of pamidronate and calcitriol on the set point of the parathyroid gland in postmenopausal hemodialysis patients with secondary hyperparathyroidism.
    Huang CY; Zheng CM; Wu CC; Lo L; Lu KC; Chu P
    Nephron Clin Pract; 2012; 122(3-4):93-101. PubMed ID: 23635416
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Disodium pamidronate for treating severe hypercalcemia in a hemodialysis patient.
    Trimarchi H; Lombi F; Forrester M; Elizondo C; Sawinski D; Pereyra H; Freixas E
    Nat Clin Pract Nephrol; 2006 Aug; 2(8):459-63; quiz 464. PubMed ID: 16932480
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Disodium pamidronate in the preoperative treatment of hypercalcemia in patients with primary hyperparathyroidism.
    Jansson S; Tisell LE; Lindstedt G; Lundberg PA
    Surgery; 1991 Sep; 110(3):480-6. PubMed ID: 1845370
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Changes in mineral metabolism in stage 3, 4, and 5 chronic kidney disease (not on dialysis)].
    Lorenzo Sellares V; Torregrosa V
    Nefrologia; 2008; 28 Suppl 3():67-78. PubMed ID: 19018742
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evaluation of secondary adrenal insufficiency: findings by corticotropin-releasing hormone test and magnetic resonance imaging in parallel.
    Lin SY; Won JG; Lee TI; Tang KT; Lin HD
    Zhonghua Yi Xue Za Zhi (Taipei); 2002 Apr; 65(4):156-63. PubMed ID: 12135194
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The use of pamidronate for hypercalcemia secondary to acute vitamin D intoxication.
    Lee DC; Lee GY
    J Toxicol Clin Toxicol; 1998; 36(7):719-21. PubMed ID: 9865241
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The hypothalamic-pituitary-adrenal axis in critical illness: response to dexamethasone and corticotropin-releasing hormone.
    Reincke M; Allolio B; Würth G; Winkelmann W
    J Clin Endocrinol Metab; 1993 Jul; 77(1):151-6. PubMed ID: 8392081
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Isolated adrenocorticotropin deficiency presenting with impaired renin-angiotensin-aldosterone system and suppressed parathyroid hormone-vitamin D axis.
    Saito T; Tojo K; Yamamoto H; Hosoya T; Tajima N
    Intern Med; 2002 Jul; 41(7):561-5. PubMed ID: 12132525
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Serum parathyroid hormone-related protein levels and response to bisphosphonate treatment in hypercalcemia of malignancy.
    Rizzoli R; Thiébaud D; Bundred N; Pecherstorfer M; Herrmann Z; Huss HJ; Rückert F; Manegold C; Tubiana-Hulin M; Steinhauer EU; Degardin M; Thürlimann B; Clemens MR; Eghbali H; Body JJ
    J Clin Endocrinol Metab; 1999 Oct; 84(10):3545-50. PubMed ID: 10522993
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Usefulness of pamidronate in severe secondary hyperparathyroidism in patients undergoing hemodialysis.
    Torregrosa JV; Moreno A; Mas M; Ybarra J; Fuster D
    Kidney Int Suppl; 2003 Jun; (85):S88-90. PubMed ID: 12753274
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Significance of plasma PTH-rp in patients with hypercalcemia of malignancy treated with bisphosphonate.
    Wimalawansa SJ
    Cancer; 1994 Apr; 73(8):2223-30. PubMed ID: 8156530
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Idiopathic isolated ACTH deficiency and the response to CRF.
    Nowakowski KJ; Tucci JR
    J Endocrinol Invest; 1989 Apr; 12(4):253-5. PubMed ID: 2545769
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Plasma adrenocorticotropin and cortisol responses to ovine corticotropin-releasing factor in patients with adrenocortical insufficiency due to hypothalamic and pituitary disorders.
    Tsukada T; Nakai Y; Koh T; Tsujii S; Inada M; Nishikawa M; Shinoda H; Kawai I; Takezawa N; Imura H
    J Clin Endocrinol Metab; 1984 Apr; 58(4):758-60. PubMed ID: 6321536
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.